Natural Alternatives International, Inc. (OQ:NAII)

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEC
Company Contact
Address: 1535 Faraday Avenue
CARLSBAD CA 92008
Tel: N/A
Website: https://www.nai-online.com
IR: See website
<
Key People
Mark A. Ledoux
Chairman of the Board of Directors, Chief Executive Officer 		Kenneth Eugene Wolf
President, Chief Operating Officer, Secretary 		Michael E. Fortin
Chief Financial Officer
Business Overview
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company's CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
Financial Overview
For the six months ended 31 December 2023, Natural Alternatives International, Inc. revenues decreased 31% to $59.2M. Net loss totaled $3.8M vs. income of $2.9M. Revenues reflect Private Label Contract Manufacturing segment decrease of 33% to $55.2M, United States segment decrease of 29% to $41.5M, Outside USA segment decrease of 34% to $17.6M.
Employees: 317 as of Jun 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $32.96M as of Dec 31, 2023
Annual revenue (TTM): $127.76M as of Dec 31, 2023
EBITDA (TTM): $1.19M as of Dec 31, 2023
Net annual income (TTM): -$4.11M as of Dec 31, 2023
Free cash flow (TTM): $4.54M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 6,088,813 as of Feb 13, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More